Daniel Jennifer 4

4 · Schrodinger, Inc. · Filed Mar 2, 2021

Form 4

Period: 2021-02-26

See Remarks

Transactions

Exercise/Conversion
Common Stock
2021-02-26$3.07/sh+3,345$10,269→ 10,033 total
Sale
Common Stock
2021-02-26$104.00/sh−3,345$347,880→ 6,688 total
Exercise/Conversion
Common Stock
2021-03-01$4.34/sh+418$1,814→ 7,106 total
Sale
Common Stock
2021-03-01$107.56/sh−418$44,960→ 6,688 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-26−3,345→ 0 total
Exercise: $3.07Exp: 2027-04-07→ Common Stock (3,345 underlying)
Award
Stock Option (right to buy)
2021-02-27+30,000→ 30,000 total
Exercise: $102.48Exp: 2031-02-27→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-03-01−418→ 9,197 total
Exercise: $4.34Exp: 2028-11-29→ Common Stock (418 underlying)

Footnotes (4)

[F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
[F2]This option was granted on April 7, 2017 and is fully vested.
[F3]The option was granted on February 27, 2021. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 27, 2022 and the remainder are scheduled to vest in equal monthly installments through February 27, 2025.
[F4]This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.

Documents

1 file